Novo Nordisk (NVO) and Eli Lilly (LLY)’s Weight-Loss Drugs Still Work at Smaller Doses, Study Finds
Covered in this story
What has happened since
- Lilly (Eli) is up 12.3% since this was published, 33 days ago.
- Novo Nordisk is down 6.5% since this was published, 33 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Lilly (Eli)
- Cantor Fitzgerald: $1.19k → $1.44k by Oct 2027 · Overweight via Stocktwits
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $LLY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Lilly (Eli) →Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.